These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 35768833)
1. Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer. Hou J; Lu Z; Cheng X; Dong R; Jiang Y; Wu G; Qu G; Xu Y BMC Cancer; 2022 Jun; 22(1):719. PubMed ID: 35768833 [TBL] [Abstract][Full Text] [Related]
2. A ferroptosis-associated lncRNAs signature predicts the prognosis of hepatocellular carcinoma. Wang D; Zhang L; Zhang Y; Zhang Y; Xu S Medicine (Baltimore); 2022 Jul; 101(28):e29546. PubMed ID: 35839000 [TBL] [Abstract][Full Text] [Related]
3. Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer. Cai HJ; Zhuang ZC; Wu Y; Zhang YY; Liu X; Zhuang JF; Yang YF; Gao Y; Chen B; Guan GX Bosn J Basic Med Sci; 2021 Oct; 21(5):569-576. PubMed ID: 33714257 [TBL] [Abstract][Full Text] [Related]
4. Construction of a necroptosis-related lncRNA signature for predicting prognosis and revealing the immune microenvironment in bladder cancer. Wang J; Jiang Z; Wang K; Zheng Q; Jian J; Liu X; Chen Z; Yang R; Wang L Aging (Albany NY); 2024 Feb; 16(3):2812-2827. PubMed ID: 38319718 [TBL] [Abstract][Full Text] [Related]
5. Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer. Hao S; Yang Z; Wang G; Cai G; Qin Y BMC Cancer; 2024 Aug; 24(1):958. PubMed ID: 39107713 [TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of a Ferroptosis-Related Long Non-coding RNA Signature for Predicting the Outcome of Lung Adenocarcinoma. Zheng Z; Zhang Q; Wu W; Xue Y; Liu S; Chen Q; Lin D Front Genet; 2021; 12():690509. PubMed ID: 34367250 [TBL] [Abstract][Full Text] [Related]
7. Identification of a prognostic signature based on five ferroptosis-related genes for diffuse large B-cell lymphoma. Li W; Yao R; Yu N; Zhang W Cancer Biomark; 2024; 40(1):125-139. PubMed ID: 38517778 [TBL] [Abstract][Full Text] [Related]
8. Ferroptosis-related gene transferrin receptor protein 1 expression correlates with the prognosis and tumor immune microenvironment in cervical cancer. Shang X; Wang H; Gu J; Zhao X; Zhang J; Sun B; Zhu X PeerJ; 2024; 12():e17842. PubMed ID: 39131609 [TBL] [Abstract][Full Text] [Related]
9. Identification of a novel five ferroptosis-related gene signature as a promising prognostic model for breast cancer. Cheng TC; Wu JH; Zhu B; Gao HY; Zheng L; Chen WX J Cancer Res Clin Oncol; 2023 Dec; 149(18):16779-16795. PubMed ID: 37728703 [TBL] [Abstract][Full Text] [Related]
10. A new ferroptosis-related signature model including messenger RNAs and long non-coding RNAs predicts the prognosis of gastric cancer patients. Liu Y; Liu Y; Ye S; Feng H; Ma L J Transl Int Med; 2023 Jun; 11(2):145-155. PubMed ID: 38025952 [TBL] [Abstract][Full Text] [Related]
11. A novel ferroptosis-related gene signature for predicting outcomes in cervical cancer. Qi X; Fu Y; Sheng J; Zhang M; Zhang M; Wang Y; Li G Bioengineered; 2021 Dec; 12(1):1813-1825. PubMed ID: 33989111 [TBL] [Abstract][Full Text] [Related]
12. Immunogenomic profiles and therapeutic options of the pan-programmed cell death-related lncRNA signature for patients with bladder cancer. Yang J; Zhang L; Zhu B; Wu H; Peng M Sci Rep; 2024 Aug; 14(1):18500. PubMed ID: 39122807 [TBL] [Abstract][Full Text] [Related]
13. Machine learning identifies the role of SMAD6 in the prognosis and drug susceptibility in bladder cancer. Chen Z; Ou Y; Ye F; Li W; Jiang H; Liu S J Cancer Res Clin Oncol; 2024 May; 150(5):264. PubMed ID: 38767747 [TBL] [Abstract][Full Text] [Related]
14. ALOX5 deficiency contributes to bladder cancer progression by mediating ferroptosis escape. Liu T; Xu X; Li J; Bai M; Zhu W; Liu Y; Liu S; Zhao Z; Li T; Jiang N; Bai Y; Jin Q; Zhang Y; Zheng Y; Zhou S; Zhan S; Sun Y; Liang G; Luo Y; Chen X; Guo H; Yang R Cell Death Dis; 2023 Dec; 14(12):800. PubMed ID: 38062004 [TBL] [Abstract][Full Text] [Related]
15. Identification and validation of basement membrane-related genes predicting prognosis and immune infiltration associated with bladder cancer. Lai F; He L; Lia T; Yang Z; Huang C Medicine (Baltimore); 2024 Jul; 103(29):e38858. PubMed ID: 39029072 [TBL] [Abstract][Full Text] [Related]
16. Integrative analysis of the molecular mechanisms, immunological features and immunotherapy response of ferroptosis regulators across 33 cancer types. Tang B; Yan R; Zhu J; Cheng S; Kong C; Chen W; Fang S; Wang Y; Yang Y; Qiu R; Lu C; Ji J Int J Biol Sci; 2022; 18(1):180-198. PubMed ID: 34975326 [TBL] [Abstract][Full Text] [Related]
17. Identification of key ferroptosis genes and mechanisms associated with breast cancer using bioinformatics, machine learning, and experimental validation. Liang S; Bai YM; Zhou B Aging (Albany NY); 2024 Jan; 16(2):1781-1795. PubMed ID: 38244591 [TBL] [Abstract][Full Text] [Related]
18. Establishment of a prognostic model to predict chemotherapy response and identification of RAC3 as a chemotherapeutic target in bladder cancer. Chen Y; Huang M; Lu J; Zhang Q; Wu J; Peng S; Chen S; Zhang Y; Cheng L; Lin T; Chen X; Huang J Environ Toxicol; 2024 Feb; 39(2):509-528. PubMed ID: 37310098 [TBL] [Abstract][Full Text] [Related]
19. Machine learning-based autophagy-related prognostic signature for personalized risk stratification and therapeutic approaches in bladder cancer. Wang Z; Chen DN; Huang XY; Zhu JM; Lin F; You Q; Lin YZ; Cai H; Wei Y; Xue XY; Zheng QS; Xu N Int Immunopharmacol; 2024 Sep; 138():112623. PubMed ID: 38991630 [TBL] [Abstract][Full Text] [Related]
20. Identification of the ferroptosis-related prognostic gene signature in mesothelioma. Wang Z; Huang J; MinYang ; Fu L; Liu S; Huang J; Han J; Zhao X Gene; 2024 Aug; 919():148498. PubMed ID: 38670397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]